Flowchart: Enrollment and outcomes of the trial. by Richard S. Legro (8086748)

Subjects:

Kaplan–Meier curves for good live birth. by Richard S. Legro (8086748)

Subjects:

Pregnancy outcomes according to intervention groups. by Richard S. Legro (8086748)

Subjects:

Kaplan–Meier curves for good live birth and live birth. by Richard S. Legro (8086748)

Subjects:

Serious adverse events (all) and adverse events (with more than 2% of patients experiencing them) between the intervention groups. by Richard S. Legro (8086748)

Subjects:

Kaplan–Meier curves for live birth. by Richard S. Legro (8086748)

Subjects:

Effect of 16-week lifestyle intervention programs on biometric and biochemical parameters. by Richard S. Legro (8086748)

Subjects:

Good live birth, live birth, and conception per study phase and treatment cycles. by Richard S. Legro (8086748)

Subjects:

Kaplan–Meier curves for pregnancy loss among those who conceived. by Richard S. Legro (8086748)

Subjects:

Baseline characteristics of the patients. by Richard S. Legro (8086748)

Subjects:

Radar graph of odds ratio visualization for disease milestones difference by age and disease duration. by Sasivimol Virameteekul (11868977)

Subjects:

Radar graph of absolute correlations between age, disease duration and disease variables. by Sasivimol Virameteekul (11868977)

Subjects:

Comparison of demographic and clinical characteristics for old-old PD patients with disease duration <10 years versus those with disease duration ≥10 years. by Sasivimol Virameteekul (11868977)

Subjects:

Distribution of the global population in 2020 [4] and prevalence of global Parkinson’s disease in 2016, by age [5]. by Sasivimol Virameteekul (11868977)

Subjects:

Comparison of demographic and clinical characteristics of old-old versus young-old PD patients. by Sasivimol Virameteekul (11868977)

Subjects:

summary of the confidence intervals. by Yohannis Derbew Molla (16471771)

“…Additionally, the overall mortality rate was 12%. However, significant variability was observed among studies.…”

PRISMA flowchart of the study selection process. by Yohannis Derbew Molla (16471771)

“…Additionally, the overall mortality rate was 12%. However, significant variability was observed among studies.…”

Discovery and Verification of Sjögren’s Syndrome Protein Biomarkers in Tears by Targeted LC-MRM by Maggy Lépine (16828939)

“…Sjögren’s syndrome (SS) is an autoimmune rheumatic disorder characterized by exocrine gland dysfunction, mainly from the lacrimal and salivary glands. The disease causes severe aqueous dry eye syndrome (DED) and is associated with high rates of complications, including corneal ulceration, scaring, and perforation. …”

Maternal complications in pregnancy and childbirth for women with epilepsy: Time trends in a nationwide cohort by Kim Christian Danielsson (8038781)

“…<div><p>Objective</p><p>Obstetric trends show changes in complication rates and maternal characteristics such as caesarean section, induced labour, and maternal age. …”

Supplementary Material for: Elderly Patients with Moderate-To-Severe Ulcerative Colitis Are More Likely to Have Treatment Failure and Adverse Outcome by Zhang M. (3218208)

“…The rate of serious infections was significantly higher in the elderly (55.4% vs. 35.1%, <i>p</i> = 0.013), mainly including cytomegalovirus infection, bacterial infection, and extraintestinal infection. …”